The Effect of Rehmanniae Radix on Bleomycin-induced Lung Fibrosis

숙지황(熟地黃)이 Bleomycin에 의한 폐섬유화(肺纖維化)에 미치는 영향(影響)

  • Rhee, Hyung-Gu (Division of Repiratory System, Department of Internal Medicine, College of Oriental Medicine, Kyunghee University) ;
  • Jung, Sung-Ki (Division of Repiratory System, Department of Internal Medicine, College of Oriental Medicine, Kyunghee University) ;
  • Jung, Hee-Jae (Division of Repiratory System, Department of Internal Medicine, College of Oriental Medicine, Kyunghee University) ;
  • Ryu, Han-Chon (Division of Repiratory System, Department of Internal Medicine, College of Oriental Medicine, Kyunghee University)
  • 이형구 (경희대학교 한의과대학 폐계내과교실) ;
  • 정승기 (경희대학교 한의과대학 폐계내과교실) ;
  • 정희재 (경희대학교 한의과대학 폐계내과교실) ;
  • 류한천 (경희대학교 한의과대학 폐계내과교실)
  • Published : 2004.06.30

Abstract

Objective : The main purpose of this study was to determine if Rehmanniae Radix has significant effects on lung fibrosis. Materials and Methods : C57BL/6J mice were devided into three groups. These were the normal group, which were not treated, the control group, given Intratracheal instillation(IT) of Bleomycin, the sample group, given IT of bleomycin and water-extracted Rehmanniae Radix. Animals were sacrificed 14 days after IT treatment. Lung fibrosis was evaluated by analysis of bronchoalveolar larvage(BAL) total WBC, percentage of macrophage, lymphocyte and neutrophil. This was done histologically by semiquantitative histological index(SHT) of lung tissue. Results : The sample group in coparison with control group showed a decrease in the BAL, total WBC, lower percentage of lymphocyte and neutrophil(p<0.05) and correspondingly a lower percentage of macrophage(p<0.01). The Sample group showed a significant decrease of collagen accumulation with respect to the control group in SHI of lung tissue(p<0.01). INF-${\gamma}$ and IL-4 levels in BALF of mice significantly decreased in the control group(p<0.05). Conclusions : Results suggest that Rehmanniae Radix has an anti-imflamatory effect and anti-fibrotic effect on the lungs through decrease of IL-4 and total WBC count for not only macrophage, but also lymphocyte and neutrophil. The degradation of INF-${\gamma}$ calls for research beyond the scope of this study.

Keywords

References

  1. Am J Respir Crit Care Med. v.161 Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement American Thoracic Society
  2. Interstitial lung disease Wyngarden, J.R.;Smith L.H. Jr.(eds.);Saunders, W.B.;CRYSTAL, R.B.
  3. 결핵 및 호흡기질환 v.54 no.2 폐 섬유화증의 병인 및 병태 생리 어수택
  4. J Clin Invest. v.72 Mechanisms of poulmonary fibrosis: Spontaneous release of the alveolar macrophage-derived growth factor in the inerstitial lung disorders Bitterman, P.B.;Adelberg, S.;Crystal, R.G.
  5. Am J Respir Crit Care Med. v.161 Idiopathic pulmonary fibrosis: diagnosis and treatment International consensus statement
  6. New approaches to managing idiopathic pulmonary fibrosis Evolving definition and approach to diagnosis of idiopathic pulmonary fibrosis Raghu, G.
  7. 東醫肺系內科學 李珩九
  8. 東醫寶鑑 許俊
  9. 偏柱醫學入門 李정
  10. 大田大學校 韓醫學硏究所 論文集 v.5 no.2 結締組織病疾에 倂發된 間質性肺疾患에 대한 活血化瘀法의 治療效果 硏究 張恒鴻
  11. 本草學 全國韓醫科大學敎授(共編著)
  12. Am. J. Respir. Crit. Care Med. v.159 Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone Raghu, G.W.;Johnson, C.;Lockhart, D.;Mageto, Y.
  13. 결핵 및 호흡기질환 v.54 no.3 특발성폐섬유증(IPF)의 치료 김동순
  14. J Clin Invest. v.72 Mechanisms of pulmnary fibrosis: Spontaneous release of the alveolar macrophage-derived growth factor in the inerstitial lung disorders Bitterman, P.B.;Adelberg, S.;Crystal, R.G.
  15. Am J Respir Crit Care Med. v.163 Bleomycin- induced chronic lung damage does not resemble human idiopathic pulmonary fibrosis Borzone, G.;Moreno, R.;Urrea, R.;Meneses, M.;Oyarzun, M.;Lisboa, C.
  16. Am J Respir Cell Mol Biol. v.27 Differences in the fibrogenic response after transfer of active transforming growth factor-betal gene to lungs of fibrosis-prone and fibrosis-resistant mouse strains Kolb, M.;Bonniaud, P.;Galt, T.;Sime, P.J.;Kelly, M.M.;Margetts, P.J.;Gauldie, J.
  17. Am Rev Respir Dis. v.140 Alveolitis and collapse in the pathogenesis of pulmonary fibrosis Burkhardt, A.
  18. Proc. Natl Acad Sci USA v.89 no.12 Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis Antoniades, H.N.;Neville-Golden, J.;Galanopoulos, T.;Kradin, R.L.;Valente, A.J.;Graves, D.T.
  19. Nihon Kyobu Shikkan Gakkai Zasshi v.31 Pathogenesis of idiopathic interstitial pneumonia/idiopathic pulmonary fibrosis: cellular and molecular biology of the disease Yoshimura, K.
  20. Probl Tuberk v.4 Role of neutrophilic leukocytes in pathogenesis of idiopathic fibrosing pulmonary alveolitis Kolodkina, L.A.;Ses', T.P.;Pokhodzei, I.V.;Orlova, G.P.
  21. J Immunol. v.171 no.5 Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsive cells Jakubzick, C.;Choi, E.S.;Joshi, B.H.;Keane, M.P.;Kunkel, S.L.;Puri, R.K.;Hogaboam, C.M.
  22. Toxicol Appl Pharmacol. v.185 no.1 Role of interferon-gamma in the development of murine bronchus-associated lymphoid tissues induced by silica in vivo Desaki, M.;Sugawara, I.;Iwakura, Y.;Yamamoto, K.;Takizawa, H.
  23. 특발성간질성폐렴환자의 IL-4와 IFN-gamma의 활성도 서기현
  24. Am J Respir Cell Mol Biol. v.24 no.5 Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin Chen, E.S.;Greenlee, B.M.;Wills-Karp, M.;Moller, D.R.
  25. 神農本草經 손성연;손빙익(輯)
  26. 本草圖經 蘇翼;상지군교
  27. 名醫別錄 陶泓景集;상지군교
  28. 湯厄本草. 東醫十種醫書 王胡吉
  29. 方藥合編 黃桃淵
  30. 方藥合編 黃桃淵